Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 16

Associations of the MIND Diet with Cardiometabolic Diseases and Their Risk Factors: A Systematic Review

Authors Akbar Z , Fituri S, Ouagueni A, Alalwani J, Sukik A, Al-Jayyousi GF, Bassil M, Tayyem R 

Received 25 July 2023

Accepted for publication 14 October 2023

Published 26 October 2023 Volume 2023:16 Pages 3353—3371

DOI https://doi.org/10.2147/DMSO.S427412

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Prof. Dr. Muthuswamy Balasubramanyam



Zoha Akbar,1 Sundus Fituri,1 Asma Ouagueni,1 Joud Alalwani,1 Ayah Sukik,1 Ghadir Fakhri Al-Jayyousi,2 Maya Bassil,1 Reema Tayyem1

1Department of Human Nutrition, College of Health Sciences, QU Health, Qatar University, Doha, Qatar; 2Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar

Correspondence: Reema Tayyem, Department of Human Nutrition, College of Health Sciences, Qatar University, Doha, 2713, Qatar, Email [email protected]

Purpose: Recent studies have expanded the scope of research on the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet beyond its impact on cognitive performance. These investigations have specifically explored its potential to provide protection against cardiometabolic diseases and associated risk factors, including obesity and dyslipidemia.
Methods: We systematically summarized and evaluated all existing observational and trial evidence for the MIND diet in relation to cardiometabolic diseases and their risk factors in adults. PubMed, Embase, CINAHL and Cochrane Library databases were systematically searched to extract original studies on humans published until September 2023, without date restrictions. A total of 491 studies were initially retrieved, out of which 23 met the eligibility criteria and were included in the final review. Duplicated and irrelevant studies were screened out by five independent reviewers using the Rayyan platform. Quality assessment was ascertained using the Newcastle-Ottawa scale for observational studies and the Cochrane risk-of-bias tool (RoB 2) for randomized trials.
Results: Across the different study designs, the MIND diet was generally associated with an improvement in anthropometric measures and other cardiometabolic outcomes, such as blood pressure, glycemic control, lipid profile, inflammation and stroke. The effects of the MIND eating pattern on some cardiovascular diseases are less conclusive.
Conclusion: The findings of this systematic review support the recommendation of the MIND diet as a strategy to reduce cardiometabolic risk in adults. Further well-designed and long-term studies are warranted.

Keywords: MIND diet, dietary patterns, cardiometabolic diseases, systematic review

Introduction

Cardiometabolic diseases are rapidly growing as a global health concern,1,2 comprising a variety of conditions including cardiovascular disease (CVD), diabetes mellitus (DM), dyslipidemia, hypertension and non-alcoholic fatty liver disease (NAFLD).3 According to the International Diabetes Federation (IDF), more than one in ten adults are now living with diabetes globally, and this number will continue to rise.4 Since the beginning of the century, the prevalence of diabetes in adults has increased more than threefold, from an estimated 151 million in the year 2000 to 537 million today. This occurs in parallel with increases in the rates of other cardiometabolic diseases. For one, CVD remains the leading cause of mortality worldwide.5 From 271 million in 1990 to 523 million in 2019, prevalent cases of CVD have almost doubled over the last 30 years.6

A substantial body of evidence exists to support the role of a healthy diet in the prevention and control of these cardiometabolic conditions.7–10 In many countries around the world, dietary guidelines are shifting their focus from nutrient-based recommendations in support of dietary-based recommendations.11–16 This shift in dietary recommendations carries forward the emphasis that nutrients and foods are not consumed in isolation, but rather in various combinations over time.17 Dietary patterns account for the synergistic and/or antagonistic effects of these combinations in the diet as a whole.18 Furthermore, the overall influence of diet on cardiometabolic disease is more likely to be caused by the combined effects of dietary components, rather than those of a single nutrient or food.

Dietary patterns rich in plant foods, such as fruits, vegetables, wholegrains, nuts, seeds and legumes, are increasingly recommended as a strategy to lower the risk of cardiometabolic diseases.10 The Mediterranean and Dietary Approaches to Stop Hypertension (DASH) diets are examples of such patterns.19,20 These diets also limit red meats, sweets, sweetened beverages and processed foods that are often associated with the Western diet, and typically linked with chronic disease.21 Several systematic reviews and meta-analyses have reported significant cardiometabolic benefits related to the adherence to the Mediterranean and DASH diets, including lower risks of DM and CVD, as well as improved blood pressure and lipid-lowering effects.22–30

In 2015, the Mediterranean and DASH diets were combined into a hybrid diet tailored specifically for the protection of the brain.31 Termed the Mediterranean-Dash Intervention for Neurodegenerative Delay (MIND), the diet emphasizes ten brain-healthy foods, namely green leafy vegetables, other vegetables, berries, nuts, beans, whole grains, fish, poultry, olive oil, and wine (Table 1).32 On the MIND diet, five brain-unhealthy foods (butter and margarine, cheese, red meat and products, fast fried foods, pastries and sweets) should be consumed in limited amounts. Hence, similar to the Mediterranean and DASH diets, the MIND diet highlights plant-based foods with limited intake of animal and saturated fat foods. It uniquely specifies the consumption of green leafy vegetables and berries, but does not emphasize other types of fruits. There are no recommendations on the consumption of potatoes and dairy products, nor does the diet recommend more than one fish meal per week.32 These features were based on a comprehensive literature review, which found that of all vegetables and fruits, green leafy vegetables and berries provided the greatest level of neuroprotection.31,33–36

Table 1 MIND Diet Components and Servings

While the MIND diet has extensively been studied in relation to cognitive performance,37,38 recent investigations examined its protective capacity on cardiometabolic diseases and their risk factors, such as obesity, inflammation and dyslipidemia.39–42 It is hypothesized that the MIND diet may have positive effects on the prevention or management of cardiometabolic diseases. This is because the MIND diet includes many components of the Mediterranean and DASH diets, which have known cardiometabolic benefits.22–30 Given the rapidly increasing aging population, there is a pressing need to address the alarming rise in the rates of cardiometabolic diseases, which are common among older adults. To our best knowledge, there is currently no comprehensive review summarizing studies on the associations of the MIND diet with cardiometabolic diseases nor any of their risk factors. Therefore, the aim of this review is to systematically summarize and evaluate all existing observational and trial evidence for the MIND diet in relation to cardiometabolic diseases and their risk factors in adults.

Methods

The current systematic review was conducted following the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines.43

Search Strategy

A literature search was conducted in PubMed, Embase, CINAHL and Cochrane Library databases until September 2023, with no date restrictions. The following keywords were employed in the search: “cardiovascular disease” OR “dyslipidemia” OR “non-insulin dependent diabetes mellitus” OR “abdominal obesity” OR “hypertension” OR “nonalcoholic fatty liver” OR “inflammation” OR “insulin resistance” OR “anthropometry” OR “metabolic syndrome” OR “cardiometabolic risk factor” OR “liver function test” OR “lipid profile” OR “glycemic control” OR “body composition” in all-fields keywords AND “Mediterranean-DASH intervention for neurodegenerative delay” OR “MIND diet” in all-fields keywords. No limits were applied to ensure the collection of all possible research papers. Details on the search strategy used are included in Supplementary Tables 15.

Eligibility Criteria

All original articles published in English language were included. Included studies were observational studies (cross-sectional, case-control and cohort studies) and interventional studies (randomized controlled trials) addressing the association of the MIND diet with cardiometabolic diseases (CVD, DM, stroke, dyslipidemia, obesity, hypertension, NAFLD) and their risk factors (anthropometric measurements, blood pressure, lipid profile, glycemia, insulin resistance, inflammation). The excluded studies were published in other languages, performed on other populations (eg, children), or examined other outcomes (eg, cognition). Furthermore, studies that investigated the association of other dietary patterns (eg, Mediterranean diet or DASH diet) with cardiometabolic diseases and their risk factors were also excluded.

Selection of Studies

The extracted studies were transferred to the Rayyan platform,44 and duplicates were removed prior to screening. The titles and abstracts of the remaining records were screened by five independent reviewers to identify articles potentially eligible for inclusion in the systematic review. In case of exclusion of any study, the reasons for exclusion were documented. The full texts of the screened studies were then critically reviewed separately by each of the five reviewers for eligibility and data extraction. Any discrepancy in evaluation between the reviewers was resolved through meetings and discussions.

Data Extraction

Data extraction of selected studies was performed and cross-checked by all five reviewers. Data from each study were extracted and categorized as follows: first author and year of publication, country, study design, follow-up duration (if applicable), sample size and characteristics, dietary assessment method and MIND diet range/categories. In studies where some components of the MIND diet were not included in the final calculation of its score, these components were also documented. Moreover, any outcome measure related to cardiometabolic diseases and their risk factors were extracted. Finally, covariates and findings accompanied by odds/hazard ratios, confidence intervals, or other indicators of association and their p-values, if available, were extracted. Results of the fully adjusted models of the studies were used to evaluate the relationship of the MIND diet with cardiometabolic parameters.

Quality Assessment

Selected studies were assessed for methodological quality by five independent reviewers. The quality and risk of bias of the included observational studies (cross-sectional, case-control and cohort studies) were assessed using the Newcastle-Ottawa quality assessment tool.45 Three main domains were assessed to determine the quality and risk of bias: selection of the exposed and non-exposed groups; comparability of groups on the basis of the design or analysis controlling for confounders; and the assessment of either outcome (cross-sectional and cohort studies) or exposure (case-control). A star system was applied to classify the articles as good, moderate, or poor quality. Studies with a total score of 6 or higher were classified as high quality. The quality of the randomized controlled trials (RCTs) was evaluated using the Cochrane Collaboration’s tool46 focusing on bias in selection, performance, detection, attrition, and reporting. In addition, bias in the matching of control and treatment groups regarding age, education and anthropometric indices were examined.

Results

Selection of Studies

As guided by the search strategy, 491 records were first retrieved, while 383 remained after removing duplicates. During the first screening phase, records were screened by title and abstract, and only 49 publications were relevant to the topic and scope of this review. An additional 26 articles were excluded after full-text screening as they did not meet the eligibility criteria. Finally, 23 articles (14 cross-sectional, 5 cohort, 1 case-control and 3 RCTs) were included in this review (Figure 1).

Figure 1 Flow diagram of the identified and screened articles on the MIND diet in relation to cardiometabolic diseases and their risk factors.

Characteristics of Included Studies

Studies included in this review varied in terms of key characteristics as shown in Table 2. Variation was observed in study design, sample size, MIND diet scoring, dietary assessment methods and sample characteristics. The majority of the studies found on the MIND diet in relation to cardiometabolic diseases were observational,39,41,42,47–63 except for three RCTs.40,64,65 All studies were published within the past six years (2018–2023). Twelve of the studies were conducted in Iran,39–41,49,53,54,57–59,61–63 one of which was an RCT.40 The rest of the studies spanned across Egypt,65 China,42,51,64 the United States48,55,56,60 and Australia.47,50,52

Table 2 Characteristics of the Included Studies on the Associations of the MIND Diet with Cardiometabolic Diseases and Their Risk Factors

Sample size varied between 37 to 10,009 participants among the different studies. The mean age of participants was above 35 years in most studies. Most studies included both males and females, except for four studies that included only women.40,41,58,65 Additionally, there were some discrepancies in the study population of the included reports. Some were conducted on healthy adults,47–49,53,56,59 three studies included overweight or obese women,40,41,58 while one included post-menopausal women with mild cognitive impairment (MCI).65 Additionally, one study recruited older adults with hypertension,64 while another was conducted on individuals with diabetes.57 The only case-control study included hospitalized stroke cases and hospitalized controls.54

For the assessment of dietary intake, most studies used Food Frequency Questionnaires (FFQs) to determine MIND diet scores. Two studies used multiple 24-hour dietary recalls.47,50 The range for the MIND diet scores varied between studies. Only six studies used the full score of 15, as they included all MIND diet components.41,47,48,56,60,64 Six studies excluded wine from the score, using a total score of 14.40,49,54,57,58,61 Another five studies excluded wine and olive oil, resulting in a total MIND diet score of 13.39,53,59,62,63 Two studies used a score of 9 due to lack of sufficient information on other MIND diet components.42,51 One study used a score range of 15–75, as the consumption of 15 food components were separated into quintiles and given a score of five for each.50 Finally, one study did not use a score, since the MIND diet was delivered as an intervention.65

The main confounders adjusted for in most studies included age, sex, energy intake, body mass index (BMI), marital status, physical activity, education status, occupation, smoking, socio-economic status, alcohol use, number of diseases and medical history of diseases (hypertension, diabetes, dyslipidemia, and heart disease). Two RCTs and one cross-sectional study did not adjust for any confounders.40,57,65

Quality of Articles

All included observational studies, except one,57 were rated as moderate to good quality (Supplementary Tables 68). Cohort studies were of moderate to good quality, with quality assessment scores ranging from five to eight (out of nine representing the lowest degree of bias) (Supplementary Table 6). The single case-control study included in this review was of moderate quality with a score of five (out of nine representing the lowest degree of bias) (Supplementary Table 7). The quality assessment scores of the fourteen cross-sectional studies ranged between three and six (out of seven representing the lowest degree of bias) (Supplementary Table 8). The main factors impairing quality of these observational studies were the self-administered questionnaires, self-reported exposures or outcomes, selection bias, confounding bias (due to lack of adjustment of important covariates) and non-response bias related to lack of information regarding certain domains. As for the randomized controlled trials, the overall risk-of-bias judgment for all RCTs had some concerns (Figure 2; Supplementary Tables 911) Reasons limiting the quality of these RCTs were lack of blinding due to the nature of the interventions and the significant differences between trial groups.

Figure 2 (a) Risk of bias summary of studies examining the effects of the MIND diet. (b) Risk of bias graph of studies examining the effects of the MIND diet.

Relationship Between MIND Diet and Cardiometabolic Diseases

Cross-Sectional Studies

The relationship between the MIND diet and cardiometabolic diseases was investigated in 14 cross sectional studies (Table 2).39,41,42,47–49,51,56–61 Seven of these studies showed no significant association between the MIND diet and cardiometabolic disease or Metabolic Syndrome (MetS).39,47,49,50,58,59,61 MetS is defined as a cluster of cardiometabolic risk factors such as central obesity, hypertension, dyslipidemia and impaired glucose tolerance.66 MIND diet adherence was negatively correlated with waist circumference, BMI, total cholesterol (TC) to high density lipoprotein cholesterol (HDL-C) ratio (TC/HDL-C) and diabetes status,39,47,48,56 and positively correlated with HDL-C (p<0.05).49,56 Additionally, lower scores in the MIND pattern were positively associated with low ankle brachial index (ABI), which indicates atherosclerosis.51 Some studies had gender specific outcomes, whereby a higher adherence to the MIND diet was negatively associated with obesity, but only in women (OR: 0.81; P<0.03).39 In another study, the inflammatory biomarker high sensitivity C-reactive protein (hs-CRP) was lower among men adhering to the MIND diet.42 One study reported a significant interaction between MIND diet and the CAV1 rs3807992 polymorphism for metabolic dyslipidemia.41

Cohort and Case-Control Studies

A total of five cohort studies tested the association between the MIND diet and cardiometabolic disease over time.52,53,55,62,63 One study showed that a higher MIND diet score was associated with lower incidence of diabetes,55 while another showed an inverse association between the MIND diet and incident CVD.53 According to Golzarand et al, as the consumption of MIND diet components increased, the risk of CVD decreased.53 Whole grains, green leafy vegetables, and beans reduced the risk of CVD by 60%, 45%, and 65%, respectively.53 On the other hand, Livingstone et al reported a positive association between the MIND diet and nonfatal CVD events (MI and stroke) (HR: 1.20; 95% CI: 1.05–1.36).52 However, this association lost its significance after excluding deaths that occurred in the first 2 years of follow-up. In addition, one study did not find an association between higher MIND diet scores and hypertension risk.62 In another study, there was a reduced risk of metabolically unhealthy phenotypes (such as elevated lipid profile, blood pressure or blood glucose) with higher MIND diet scores.63 One case control study conducted in Iran included participants aged over 45 years that were recruited as hospitalized stroke cases and hospital-based controls. The study found that the MIND diet score was inversely associated with the odds of stroke (T3 vs T1 OR: 0.41; 95% CI: 0.18–0.94).54

Randomized Controlled Trials

The effect of the MIND diet intervention on cardiometabolic diseases or their risk factors was reported in three single-blind randomized controlled trials conducted on three different populations.40,64,65 After a four-week intervention on older adults with hypertension, the MIND diet decreased waist-to-hip ratio (WHR) by 0.03 (p=0.050) compared to the control group.64 Total cholesterol and LDL-C decreased by 0.60 mmol/L and 0.33 mmol/L in the MIND diet group (compared to 0.57 and 0.28 mmol/L in the control group), respectively. Additionally, blood glucose levels decreased significantly by 0.68 mmol/L in the MIND diet group.64 In a 3-month trial on healthy overweight and obese women, the effects of a calorie-restricted MIND diet and a calorie-restricted control diet on anthropometric measures were investigated. The MIND diet group participants experienced a significant reduction in weight (–3.98±–0.29), BMI (–1.55±–0.11), percentage of body fat (–5.16±–0.82), and waist circumference (–3.54±0.56).40 Furthermore, a trial on 60 postmenopausal women with mild cognitive impairment (MCI) also showed that participants following the MIND diet significantly reduced their body weight and BMI after 12 weeks of intervention (p<0.05).65

Discussion

This is the first systematic review to assess the relationship between the MIND diet and cardiometabolic diseases and their risk factors. Overall, the included studies indicated that adherence to the MIND diet was associated with favorable cardiometabolic outcomes in adults. Across all the different study designs, a desirable significant effect was observed on obesity and anthropometric indicators, including waist circumference,40,47,48,56 WHR64 and BMI.40,48,65 Significant improvements were also found in blood pressure,57 glycemic outcomes,48,56 HDL,47–49,56 triglycerides,56,64 and total cholesterol.64 Moreover, the MIND diet was found to reduce inflammatory markers,42 as well as the incidence of DM,55 CVD,53 stroke54 and atherosclerosis.51 However, no significant effect was found for systolic blood pressure,64 metabolic syndrome,47,49 HDL,64 body fat percent (BFP),64 and other markers of cardiovascular disease risk in some studies.50

Anthropometric Measurements

The studies included in this systematic review reported on several anthropometric measures. In RCTs, the MIND diet was associated with a reduction in waist circumference, BMI, WHR and weight, whereas effects on BFP were conflicting.40,64,65 Yau et al reported no effect of the dietary intervention on BFP in comparison to the control group, which may be due to lower levels of body fat at baseline. Cross-sectional investigations also revealed negative correlations with waist circumference,47,56 general obesity39,49 and BMI,48 but no association with abdominal obesity.49 As cross-sectional studies are observational in nature and report on current intake, the discrepancy in abdominal obesity may be explained by the energy-restricted interventions employed in the RCTs. Nonetheless, previous evidence indicates that increased consumption of MUFAs in the form of olive oil and nuts, as in the MIND diet, is not related to visceral fat deposition or weight gain.67–71 The overall findings of beneficial anthropometric effects are in line with other dietary patterns rich in MIND diet components, such as the Mediterranean and DASH diets.72–75

Lipid Profile

In the present systematic review, the MIND diet was generally associated with a beneficial effect on lipid biomarkers. Of the included RCTs, Yau et al reported a reduction in triglycerides, TC and LDL-C in the MIND diet group.64 In cross-sectional studies, MIND diet was positively associated with HDL-C47,49,56 and negatively related to TC/HDL-C ratio.48 Similar findings have been reported for the DASH diet, which shares many components with the MIND eating pattern.23,75 The results for these biomarkers were comparable across different study designs, except for TG. In a cross-sectional analysis, Holthaus et al reported an inverse association of TG with high MIND diet scores,56 while Mohammadpour et al reported no significant association between a higher MIND diet score and the odds of high serum TG.49 This may be explained by the high intake of red meat and margarine by participants in the highest tertile (T3) of the MIND diet, apart from a high intake of brain healthy foods. The intake of these foods should be limited to a certain number of servings per day in the MIND eating pattern.

Glycemic Control and Type 2 Diabetes

Seven studies evaluated the MIND diet and its effects on glycemia.48,49,55–57,61,64 The RCT by Yau et al showed a reduction in glucose levels in the MIND group, and these results were supported by some of the observational research included in this review. A cohort study showed that high MIND diet scores were associated with lower incidence of diabetes.55 In two cross-sectional studies in the USA, the MIND diet was negatively correlated with DM48 and FBS,56 respectively. However, no association was found with fasting blood glucose in three Iranian studies.49,57,61 Published literature on the effect of the Mediterranean and DASH diets on glycemic measures has been somewhat inconsistent. While Mediterranean diets have shown beneficial effects on glycemic profile,76,77 some meta-analyses of DASH did not find a significant association with blood glucose.75,78

Blood Pressure and Hypertension

Nine observational studies and one RCT included in the systematic review reported on blood pressure.47–49,56,57,60,61,63,64 Some observational studies showed that blood pressure was inversely related to the MIND diet,56,57,60 while others did not.48,61 For instance, Mohammadpour et al found no association between elevated blood pressure and the MIND eating pattern.49 This could be explained by the baseline value of blood pressure in tertile 3, which was already much lower than tertile 1 and 2. Further, the MIND diet was not associated with SBP in the RCT. In addition, a cohort study did not find an association between higher MIND diet scores and hypertension risk.62 Comparing to the two dietary patterns that the MIND diet is derived from, while the DASH diet has been studied extensively for its beneficial effects on blood pressure,22,79,80 the evidence on the Mediterranean diet and improved blood pressure outcomes is compelling,81–83 but not conclusive.84,85 Further trials and longitudinal studies are needed before the MIND diet can be recommended as an intervention for controlling blood pressure.

Cardiovascular Disease

Several observational studies reported on the association of the MIND diet with cardiovascular diseases, such as coronary heart disease (CHD), heart failure, stroke, as well as atherosclerosis.50–54 An inverse association between the MIND diet and stroke was reported in one cohort53 and one case-control study.54 Although the association between the MIND diet and stroke has not been widely studied, these findings are in agreement with the protective effects of the Mediterranean and DASH diets, from which the MIND diet is derived.86–88 In the same cohort, MIND diet was also inversely related to coronary heart disease.53 One cross-sectional study reported a positive association between low MIND diet score and low ankle-brachial index (ABI), which is an indication of atherosclerosis.51 This is in line with evidence on the Mediterranean and DASH dietary patterns, which have been strongly linked to lower risks of CVD.28,89 In another cross-sectional study, the MIND diet was found to be unrelated to CVDs, including ischemic heart disease, CHD, angina, heart failure and cerebrovascular disease.50 However, upon exclusion of participants who misreported their energy intake, an inverse association was found between the MIND diet and heart failure only. The lack of a relationship with most CVDs that was observed in this study may be partly explained by the narrow range of MIND diet scores that were present in the sample, which may have affected the ability to detect the associations.

Inflammation

One cross-sectional study in this review found an association between the MIND diet and reduced hsCRP in men, suggesting a protective effect against inflammation.42 This finding is generally in line with observations from the literature, in which similar diets of higher quality, such as the Mediterranean and DASH diets, were associated with a lower level of CRP.90–92 The lack of an observed association in women in the study by Chan et al may be partly explained by the incomplete dietary assessment in the study. The maximum score of MIND adherence was 9 instead of 15, as the authors reported insufficient information to determine the use of olive oil and the consumption of fish, beans, poultry, red meat and products, and fast fried foods.42 Western dietary patterns characterized by high intake of red meats and fried foods have been previously related to increased levels of CRP.93 A conclusion on the effect of the MIND diet on inflammation in women cannot be drawn without such crucial information on their dietary intake. Furthermore, the gender difference may also be explained by the heterogeneity in the dietary patterns of men in the study. Hence, the benefits of the MIND diet components were more easily detected in men than in women, ultimately showing a reduction in their CRP.42

Mechanisms

The MIND eating pattern is derived from the Mediterranean and DASH diets to include components with the strongest evidence for cognitive health. Diabetes and hypertension are risk factors for Alzheimer’s disease, and the pathogenesis for neurocognitive disorders lies within similar pathways as cardiometabolic diseases.94 Therefore, it is reasonable to presume that similar to the Mediterranean95–97 and DASH eating patterns,22 the MIND diet would also have cardiometabolic benefits.

One proposed mechanism behind the association between the MIND diet with cardiometabolic diseases could be attributed to its components that are rich in antioxidants and anti-inflammatory molecules.32 The MIND diet consists of ten brain-healthy foods (green leafy vegetables, other vegetables, berries, nuts, beans, whole grains, fish, poultry, olive oil, and wine), which are known to have cardiometabolic protective properties.32 A 3-year prospective cohort study found that a high adherence to the healthful plant-based diet index (hPDI), which is rich in whole grains, fruits, vegetables, nuts, legumes, vegetable oils, and tea/coffee, was inversely associated with T2DM (HR: 0.55; 95% CI 0.51–0.59, p<0.001) in American adults.98 This negative association could be explained by the high content of bio-active substances known as phytochemicals found in plants, mainly the green leafy vegetables.99,100 The MIND diet is rich in phytochemicals, a group of more than 5000 compounds that have been established to reduce the risk of different chronic diseases.100

Furthermore, the MIND diet specifies high consumption of berries, which are rich in specific phytochemicals termed flavonoids.32 Flavonoids are known to play a significant role in cardiometabolic health by improving oxidative stress, insulin sensitivity, glucose tolerance, inflammatory status, lipid metabolism, and adipocyte differentiation.101–104 Moreover, in-vitro and in-vivo studies have revealed that flavonoids can be promising anti-diabetic phytochemicals.105 Another potential mechanism appears to be linked to the role of the MIND diet in upregulating genes involved in mitochondrial respiration and oxidative phosphorylation.106 Mitochondrial dysfunction is associated with a reduction in these processes and leads to an increase in reactive oxygen species, which are implicated in the progression of cardiometabolic diseases, inflammation and insulin resistance.107,108

The MIND diet was originally developed for cognitive health and has been extensively studied in observational research for its benefits on cognition via mechanisms similar to those discussed above.37,109 Recently, the first RCT comparing the MIND diet to a control diet with mild caloric restriction showed no significant changes in cognition and brain structure between the two groups.110 Additionally, the incidence of adverse events was similar in both groups and was not associated with the diets. Although comparable outcomes were observed across both groups, the findings highlight the MIND diet as a potential dietary pattern that could be adopted to reduce risk factors associated with the pathogenesis of cardiometabolic and cognitive diseases. Given the observed null association, it may be conceivable that individuals in the control group enhanced their diets, as indicated by comparable weight loss observed across both groups. Additionally, there is a possibility that repeated testing improved cognitive markers, and an extended period greater than three years would be required to observe positive effects related to diet. Further, long-term trials are necessary to validate the findings of the MIND diet observed in various prospective studies.

Strengths

The current systematic review is the first to summarize all available evidence on the association of the MIND diet with cardiometabolic diseases. An extensive search of four databases was conducted by 5 independent reviewers, which may help to reduce publication bias. Each article was carefully reviewed and critically appraised using well-established tools. Studies included in the review spanned across 5 different countries (USA, Australia, Iran, China, Egypt), improving the generalizability and applicability of the findings. The prospective cohorts all had large sample sizes (>2000 participants), which enhances the precision of the estimates. The overall quality of the observational studies was judged as moderate to good, and one RCT had a low risk of bias. Most of the included studies used validated dietary assessment tools, mainly food frequency questionnaires. Another strength is the adjustment for key confounders (eg, energy intake and BMI) by many of the included studies, which helps to illustrate the independent relationship between the MIND diet and cardiometabolic diseases. Furthermore, as an a priori dietary pattern, the MIND diet can be easily compared with other studies, an added strength to this review.

Limitations

The review has several limitations. For one, out of twenty-three studies included, fourteen were cross-sectional in design, which limits temporality and causality. Second, some studies had small sample sizes (<100 participants), which might affect their overall power. Third, many studies excluded some MIND diet components from their score due to lack of sufficient information from the participants. Most importantly, eight studies excluded olive oil, a key component of the MIND diet. Given the established protective effects of dietary patterns high in olive oil on cardiometabolic outcomes, the findings from these studies should be interpreted with caution. Some components of the MIND diet require assessment of weekly consumption, which could not be applied to studies that used 24-hour recalls. However, the collection of multiple 24-hour recalls on non-consecutive days may be used to estimate usual dietary intakes in group settings.111 In addition, while most studies employed validated FFQs, this method of dietary assessment is prone to recall bias or reporting errors. In addition, the heterogeneity among the studies, such as in their designs, populations and outcomes, makes it difficult to compare results. Lastly, although most studies used multivariable models, the possibility of residual confounding cannot be fully ruled out.

Conclusion

In conclusion, the MIND diet appears to be associated with improvements in cardiometabolic parameters, including anthropometric measures, lipid profile, inflammation and incidence of stroke. However, due to heterogeneity among the included studies, the results should be interpreted with caution. Nonetheless, given the demonstrated effectiveness of the MIND diet in managing Alzheimer’s disease, which shares similar pathways and risk factors with cardiometabolic diseases, this healthful eating pattern may have the potential to play a role in disease risk reduction. With an increase in the aging population and the prevalence of multiple comorbidities, including cognitive and cardiometabolic diseases, healthy dietary patterns like the MIND diet should be promoted as a strategy for prevention. Further well-designed and long-term studies are warranted to confirm these findings.

Ethics Policies

This research did not require ethical approval.

Acknowledgment

We thank Qatar National Library for providing open access funding for the publishing of this review.

Author Contributions

All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

Funding

This work has not received any funding.

Disclosure

The authors declare that they have no competing or conflicts of interest for this study.

References

1. Sattar N, Gill JMR, Alazawi W. Improving prevention strategies for cardiometabolic disease. Nat Med. 2020;26(3):320–325. doi:10.1038/s41591-020-0786-7

2. Miranda JJ, Barrientos-Gutiérrez T, Corvalan C, et al. Understanding the rise of cardiometabolic diseases in low- and middle-income countries. Nat Med. 2019;25(11):1667–1679. doi:10.1038/s41591-019-0644-7

3. Ndisang JF, Rastogi S. Cardiometabolic diseases and related complications: current status and future perspective. Biomed Res Int. 2013;2013:467682. doi:10.1155/2013/467682

4. Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183(109119):109119. doi:10.1016/j.diabres.2021.109119

5. Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The global burden of cardiovascular diseases and risk: a compass for future health. J Am Coll Cardiol. 2022;80(25):2361–2371. doi:10.1016/j.jacc.2022.11.005

6. Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update From the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982–3021.

7. Badimon L, Chagas P, Chiva-Blanch G. Diet and cardiovascular disease: effects of foods and nutrients in classical and emerging cardiovascular risk factors. Curr Med Chem. 2019;26(19):3639–3651. doi:10.2174/0929867324666170428103206

8. Papamichou D, Panagiotakos DB, Itsiopoulos C. Dietary patterns and management of type 2 diabetes: a systematic review of randomised clinical trials. Nutr Metab Cardiovasc Dis. 2019;29(6):531–543. doi:10.1016/j.numecd.2019.02.004

9. Ley SH, Hamdy O, Mohan V, Hu FB. Prevention and management of type 2 diabetes: dietary components and nutritional strategies. Lancet. 2014;383(9933):1999–2007. doi:10.1016/S0140-6736(14)60613-9

10. Petersen KS, Flock MR, Richter CK, Mukherjea R, Slavin JL, Kris-Etherton PM. Healthy dietary patterns for preventing cardiometabolic disease: the role of plant-based foods and animal products. Curr Dev Nutr. 2017;1(12):cdn.117.001289. doi:10.3945/cdn.117.001289

11. Snetselaar LG, de Jesus JM, DeSilva DM, Stoody EE. Dietary Guidelines for Americans, 2020–2025: understanding the scientific process, guidelines, and key recommendations. Nutr Today. 2021;56(6):287–295. doi:10.1097/NT.0000000000000512

12. Wingrove K, Lawrence MA, McNaughton SA. Dietary patterns, foods and nutrients: a descriptive analysis of the systematic reviews conducted to inform the Australian Dietary Guidelines. Nutr Res Rev. 2021;34(1):117–124. doi:10.1017/S0954422420000190

13. Kromhout D, Spaaij CJK, de Goede J, Weggemans RM. The 2015 Dutch food-based dietary guidelines. Eur J Clin Nutr. 2016;70(8):869–878. doi:10.1038/ejcn.2016.52

14. Pinho-Gomes AC, Kaur A, Scarborough P, Rayner M. Are the eatwell guide and nutrient profiling models consistent in the UK? Nutrients. 2021;13(8):2732. doi:10.3390/nu13082732

15. Slater JJ, Mudryj AN. Are we really “eating well with Canada’s food guide”? BMC Public Health. 2018;18(1):652. doi:10.1186/s12889-018-5540-4

16. Al Thani M, Al Thani AA, Al-Chetachi W, et al. Adherence to the Qatar dietary guidelines: a cross-sectional study of the gaps, determinants and association with cardiometabolic risk amongst adults. BMC Public Health. 2018;18(1):503. doi:10.1186/s12889-018-5400-2

17. Hu FB. Dietary pattern analysis: a new direction in nutritional epidemiology. Curr Opin Lipidol. 2002;13(1):3–9. doi:10.1097/00041433-200202000-00002

18. van Dam RM. New approaches to the study of dietary patterns. Br J Nutr. 2005;93(5):573–574. doi:10.1079/BJN20051453

19. Widmer RJ, Flammer AJ, Lerman LO, Lerman A. The Mediterranean diet, its components, and cardiovascular disease. Am J Med. 2015;128(3):229–238. doi:10.1016/j.amjmed.2014.10.014

20. Filippou CD, Tsioufis CP, Thomopoulos CG, et al. Dietary Approaches to Stop Hypertension (DASH) diet and blood pressure reduction in adults with and without hypertension: a systematic review and meta-analysis of randomized controlled trials. Adv Nutr. 2020;11(5):1150–1160. doi:10.1093/advances/nmaa041

21. Kopp W. How Western diet and lifestyle drive the pandemic of obesity and civilization diseases. Diabetes Metab Syndr Obes. 2019;12:2221–2236. doi:10.2147/DMSO.S216791

22. Chiavaroli L, Viguiliouk E, Nishi SK, et al. DASH dietary pattern and cardiometabolic outcomes: an umbrella review of systematic reviews and meta-analyses. Nutrients. 2019;11(2):338. doi:10.3390/nu11020338

23. Siervo M, Lara J, Chowdhury S, Ashor A, Oggioni C, Mathers JC. Effects of the Dietary Approach to Stop Hypertension (DASH) diet on cardiovascular risk factors: a systematic review and meta-analysis. Br J Nutr. 2015;113(1):1–15. doi:10.1017/S0007114514003341

24. Salehi-Abargouei A, Maghsoudi Z, Shirani F, Azadbakht L. Effects of Dietary Approaches to Stop Hypertension (DASH)-style diet on fatal or nonfatal cardiovascular diseases—Incidence: a systematic review and meta-analysis on observational prospective studies. Nutrition. 2013;29(4):611–618. doi:10.1016/j.nut.2012.12.018

25. Jannasch F, Kröger J, Schulze MB. Dietary patterns and type 2 diabetes: a systematic literature review and meta-analysis of prospective studies. J Nutr. 2017;147(6):1174–1182. doi:10.3945/jn.116.242552

26. Franquesa M, Pujol-Busquets G, García-Fernández E, et al. Mediterranean diet and cardiodiabesity: a systematic review through evidence-based answers to key clinical questions. Nutrients. 2019;11(3):655. doi:10.3390/nu11030655

27. Martínez-González MA, Gea A, Ruiz-Canela M. The Mediterranean diet and cardiovascular health. Circ Res. 2019;124(5):779–798. doi:10.1161/CIRCRESAHA.118.313348

28. Rosato V, Temple NJ, La Vecchia C, Castellan G, Tavani A, Guercio V. Mediterranean diet and cardiovascular disease: a systematic review and meta-analysis of observational studies. Eur J Nutr. 2019;58(1):173–191. doi:10.1007/s00394-017-1582-0

29. Esposito K, Maiorino MI, Bellastella G, Chiodini P, Panagiotakos D, Giugliano D. A journey into a Mediterranean diet and type 2 diabetes: a systematic review with meta-analyses. BMJ Open. 2015;5(8):e008222. doi:10.1136/bmjopen-2015-008222

30. Martín-Peláez S, Fito M, Castaner O. Mediterranean diet effects on type 2 diabetes prevention, disease progression, and related mechanisms. a review. Nutrients. 2020;12(8):2236. doi:10.3390/nu12082236

31. Morris MC, Tangney CC, Wang Y, et al. MIND diet slows cognitive decline with aging. Alzheimers Dement. 2015;11(9):1015–1022. doi:10.1016/j.jalz.2015.04.011

32. Morris MC, Tangney CC, Wang Y, Sacks FM, Bennett DA, Aggarwal NT. MIND diet associated with reduced incidence of Alzheimer’s disease. Alzheimers Dement. 2015;11(9):1007–1014. doi:10.1016/j.jalz.2014.11.009

33. Morris MC, Evans DA, Tangney CC, Bienias JL, Wilson RS. Associations of vegetable and fruit consumption with age-related cognitive change. Neurology. 2006;67(8):1370–1376. doi:10.1212/01.wnl.0000240224.38978.d8

34. Kang JH, Ascherio A, Grodstein F. Fruit and vegetable consumption and cognitive decline in aging women. Ann Neurol. 2005;57(5):713–720. doi:10.1002/ana.20476

35. Willis LM, Shukitt-Hale B, Joseph JA. Recent advances in berry supplementation and age-related cognitive decline. Curr Opin Clin Nutr Metab Care. 2009;12(1):91–94. doi:10.1097/MCO.0b013e32831b9c6e

36. Devore EE, Kang JH, Breteler MMB, Grodstein F. Dietary intakes of berries and flavonoids in relation to cognitive decline. Ann Neurol. 2012;72(1):135–143. doi:10.1002/ana.23594

37. Kheirouri S, Alizadeh M. MIND diet and cognitive performance in older adults: a systematic review. Crit Rev Food Sci Nutr. 2022;62(29):8059–8077. doi:10.1080/10408398.2021.1925220

38. van den Brink AC, Brouwer-Brolsma EM, Berendsen AAM, van de Rest O. The Mediterranean, Dietary Approaches to Stop Hypertension (DASH), and Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diets are associated with less cognitive decline and a lower risk of Alzheimer’s disease-a review. Adv Nutr. 2019;10(6):1040–1065. doi:10.1093/advances/nmz054

39. Aminianfar A, Hassanzadeh Keshteli A, Esmaillzadeh A, Adibi P. Association between adherence to MIND diet and general and abdominal obesity: a cross-sectional study. Nutr J. 2020;19(1):15. doi:10.1186/s12937-020-00531-1

40. Arjmand G, Abbas-Zadeh M, Fardaei M, Eftekhari MH. The Effect of Short-term Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet on hunger hormones, anthropometric parameters, and brain structures in middle-aged overweight and obese women: a randomized controlled trial. Iran J Med Sci. 2022;47(5):422–432. doi:10.30476/IJMS.2021.90829.2180

41. Khatibi N, Mirzababaei A, Shiraseb F, Abaj F, Koohdani F, Mirzaei K. Interactions between caveolin 1 polymorphism and the Mediterranean and Mediterranean-DASH Intervention for Neurodegenerative Delay diet (MIND) diet on metabolic dyslipidemia in overweight and obese adult women: a cross-sectional study. BMC Res Notes. 2021;14(1):364. doi:10.1186/s13104-021-05777-4

42. Chan R, Yu B, Leung J, Lee JSW, Woo J. Association of dietary patterns with serum high-sensitivity C-reactive protein level in community-dwelling older adults. Clin Nutr ESPEN. 2019;31:38–47. doi:10.1016/j.clnesp.2019.03.004

43. Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):89. doi:10.1186/s13643-021-01626-4

44. Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan—a web and mobile app for systematic reviews. Syst Rev. 2016;5(1). doi:10.1186/s13643-016-0384-4

45. Lo CK, Mertz D, Loeb M. Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessments. BMC Med Res Methodol. 2014;14(1):45. doi:10.1186/1471-2288-14-45

46. Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. doi:10.1136/bmj.l4898

47. Gauci S, Young LM, Arnoldy L, et al. The association between diet and cardio-metabolic risk on cognitive performance: a cross-sectional study of middle-aged Australian adults. Front Nutr. 2022;9:862475. doi:10.3389/fnut.2022.862475

48. Walker ME, O’Donnell AA, Himali JJ, et al. Associations of the Mediterranean-dietary approaches to stop hypertension intervention for neurodegenerative delay diet with cardiac remodelling in the community: the Framingham Heart Study. Br J Nutr. 2021;126(12):1888–1896. doi:10.1017/S0007114521000660

49. Mohammadpour S, Ghorbaninejad P, Janbozorgi N, Shab-Bidar S. Associations between adherence to MIND diet and metabolic syndrome and general and abdominal obesity: a cross-sectional study. Diabetol Metab Syndr. 2020;12(1):101. doi:10.1186/s13098-020-00611-6

50. Wong MMH, Grech A, Louie JCY. Dietary patterns and cardiovascular disease in Australian adults: findings from the 2011–12 Australian Health Survey. Nutr Metab Cardiovasc Dis. 2020;30(5):738–748. doi:10.1016/j.numecd.2020.02.002

51. Woo J, Yu BWM, Chan RSM, Leung J. Influence of dietary patterns and inflammatory markers on atherosclerosis using ankle brachial index as a surrogate. J Nutr Health Aging. 2018;22(5):619–626. doi:10.1007/s12603-018-1031-7

52. Livingstone KM, Milte CM, Torres SJ, et al. Nineteen-year associations between three diet quality indices and all-cause and cardiovascular disease mortality: the Australian diabetes, obesity, and lifestyle study. J Nutr. 2022;152(3):805–815. doi:10.1093/jn/nxab386

53. Golzarand M, Mirmiran P, Azizi F. Adherence to the MIND diet and the risk of cardiovascular disease in adults: a cohort study. Food Funct. 2022;13(3):1651–1658. doi:10.1039/D1FO02069B

54. Salari-Moghaddam A, Nouri-Majd S, Shakeri F, et al. The association between adherence to the MIND diet and stroke: a case-control study. Nutr Neurosci. 2022;25(9):1956–1961. doi:10.1080/1028415X.2021.1918982

55. Tison SE, Shikany JM, Long DL, et al. Differences in the Association of Select Dietary Measures With Risk of Incident Type 2 Diabetes. Diabetes Care. 2022;45(11):2602–2610. doi:10.2337/dc22-0217

56. Holthaus TA, Sethi S, Cannavale CN, et al. MIND dietary pattern adherence is inversely associated with visceral adiposity and features of metabolic syndrome. Nutr Res. 2023;116:69–79. doi:10.1016/j.nutres.2023.06.001

57. Zare S, Arjmand G, Eftekhari MH, Zare M. Adherence to Mediterranean-Dash Intervention for Neurodegenerative Delay (MIND) dietary pattern in elderly with type 2 diabetes and the correlation with cognitive functions and metabolic profile. Int J Nutr Sci. 2023;8(2):102–108.

58. Khadem A, Shiraseb F, Mirzababaei A, Noori S, Mirzaei K. Association of Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet and metabolically unhealthy overweight/obesity phenotypes among Iranian women: a cross sectional study. BMC Endocr Disord. 2023;23(1):84. doi:10.1186/s12902-023-01333-2

59. Fateh HL, Muhammad SS, Kamari N. Associations between adherence to MIND diet and general obesity and lipid profile: a cross-sectional study. Front Nutr. 2023;10:1078961. doi:10.3389/fnut.2023.1078961

60. Song Y, Chang Z, Cui K, et al. The value of the MIND diet in the primary and secondary prevention of hypertension: a cross-sectional and longitudinal cohort study from NHANES analysis. Front Nutr. 2023;10. doi:10.3389/fnut.2023.1129667

61. Ardekani AM, Vahdat S, Hojati A, et al. Evaluating the association between the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet, mental health, and cardio-metabolic risk factors among individuals with obesity. BMC Endocr Disord. 2023;23(1). doi:10.1186/s12902-023-01284-8

62. Razmpoosh E, Moslehi N, Abdollahi S, Soltani S, Mirmiran P, Azizi F. The Mediterranean, DASH, and MIND diets and the incident of hypertension over a median follow-up of 7.4 years in the Tehran Lipid and Glucose Study. BMC Public Health. 2022;22(1). doi:10.1186/s12889-022-14843-w

63. Golzarand M, Moslehi N, Mirmiran P, Azizi F. Adherence to the DASH, MeDi, and MIND diet scores and the incidence of metabolically unhealthy phenotypes. Obes Res Clin Pract. 2023;17(3):226–232. doi:10.1016/j.orcp.2023.04.001

64. Yau KY, Law PS, Wong CN. Cardiac and mental benefits of Mediterranean-DASH intervention for neurodegenerative delay (MIND) diet plus forest bathing (FB) versus MIND diet among older Chinese adults: a randomized controlled pilot study. Int J Environ Res Public Health. 2022;19(22):14665. doi:10.3390/ijerph192214665

65. Elsayed MM, Rabiee A, El Refaye GE, Elsisi HF. Aerobic exercise with Mediterranean-DASH intervention for neurodegenerative delay diet promotes brain cells’ longevity despite sex hormone deficiency in postmenopausal women: a randomized controlled trial. Oxid Med Cell Longev. 2022;2022:4146742. doi:10.1155/2022/4146742

66. Fahed G, Aoun L, Bou Zerdan M, et al. Metabolic syndrome: updates on pathophysiology and management in 2021. Int J Mol Sci. 2022;23(2):786. doi:10.3390/ijms23020786

67. Bes-Rastrollo M, Sánchez-Villegas A, de la Fuente C, de Irala J, Martinez JA, Martínez-González MA. Olive oil consumption and weight change: the SUN prospective cohort study. Lipids. 2006;41(3):249–256. doi:10.1007/s11745-006-5094-6

68. Martínez-González MA, Bes-Rastrollo M. Nut consumption, weight gain and obesity: epidemiological evidence. Nutr Metab Cardiovasc Dis. 2011;21 Suppl 1:S40–S45. doi:10.1016/j.numecd.2010.11.005

69. Calder PC, Harvey DJ, Pond CM, Newsholme EA. Site-specific differences in the fatty acid composition of human adipose tissue. Lipids. 1992;27(9):716–720. doi:10.1007/BF02536031

70. Haffner SM. Abdominal adiposity and cardiometabolic risk: do we have all the answers? Am J Med. 2007;120(9 Suppl 1):S10–S16; discussion S16–S17. doi:10.1016/j.amjmed.2007.06.006

71. Prasad DS, Kabir Z, Dash AK, Das BC. Abdominal obesity, an independent cardiovascular risk factor in Indian subcontinent: a clinico epidemiological evidence summary. J Cardiovasc Dis Res. 2011;2(4):199–205. doi:10.4103/0975-3583.89803

72. Funtikova AN, Benítez-Arciniega AA, Gomez SF, Fitó M, Elosua R, Schröder H. Mediterranean diet impact on changes in abdominal fat and 10-year incidence of abdominal obesity in a Spanish population. Br J Nutr. 2014;111(8):1481–1487. doi:10.1017/S0007114513003966

73. Agnoli C, Sieri S, Ricceri F, et al. Adherence to a Mediterranean diet and long-term changes in weight and waist circumference in the EPIC-Italy cohort. Nutr Diabetes. 2018;8(1):1–10. doi:10.1038/s41387-018-0023-3

74. Soltani S, Shirani F, Chitsazi MJ, Salehi-Abargouei A. The effect of dietary approaches to stop hypertension (DASH) diet on weight and body composition in adults: a systematic review and meta-analysis of randomized controlled clinical trials. Obes Rev. 2016;17(5):442–454. doi:10.1111/obr.12391

75. Lari A, Sohouli MH, Fatahi S, et al. The effects of the Dietary Approaches to Stop Hypertension (DASH) diet on metabolic risk factors in patients with chronic disease: a systematic review and meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2021;31(10):2766–2778. doi:10.1016/j.numecd.2021.05.030

76. Kalkuz S, Demircan A. Effects of the Mediterranean diet adherence on body composition, blood parameters and quality of life in adults. Postgrad Med J. 2021;97(1154):798–802. doi:10.1136/postgradmedj-2020-138667

77. Esposito K, Maiorino MI, Ceriello A, Giugliano D. Prevention and control of type 2 diabetes by Mediterranean diet: a systematic review. Diabetes Res Clin Pract. 2010;89(2):97–102. doi:10.1016/j.diabres.2010.04.019

78. Shirani F, Salehi-Abargouei A, Azadbakht L. Effects of Dietary Approaches to Stop Hypertension (DASH) diet on some risk for developing type 2 diabetes: a systematic review and meta-analysis on controlled clinical trials. Nutrition. 2013;29(7–8):939–947. doi:10.1016/j.nut.2012.12.021

79. Moore TJ, Conlin PR, Ard J, Svetkey LP. DASH (Dietary Approaches to Stop Hypertension) diet is effective treatment for stage 1 isolated systolic hypertension. Hypertension. 2001;38(2):155–158. doi:10.1161/01.HYP.38.2.155

80. Francisco SC, Araújo LF, Griep RH, et al. Adherence to the Dietary Approaches to Stop Hypertension (DASH) and hypertension risk: results of the Longitudinal Study of Adult Health (ELSA-Brasil). Br J Nutr. 2020;123(9):1068–1077. doi:10.1017/S0007114520000124

81. Toledo E, Hu FB, Estruch R, et al. Effect of the Mediterranean diet on blood pressure in the PREDIMED trial: results from a randomized controlled trial. BMC Med. 2013;11(1):207. doi:10.1186/1741-7015-11-207

82. Psaltopoulou T, Naska A, Orfanos P, Trichopoulos D, Mountokalakis T, Trichopoulou A. Olive oil, the Mediterranean diet, and arterial blood pressure: the Greek European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr. 2004;80(4):1012–1018. doi:10.1093/ajcn/80.4.1012

83. Ahmed FS, Wade AT, Guenther BA, Murphy KJ, Elias MF. Adherence to a Mediterranean diet associated with lower blood pressure in a US sample: findings from the Maine-Syracuse Longitudinal Study. J Clin Hypertens. 2020;22(12):2276–2284. doi:10.1111/jch.14068

84. Pitsavos C, Chrysohoou C, Panagiotakos DB, Lentzas Y, Stefanadis C. Abdominal obesity and inflammation predicts hyper- tension among prehypertensive men and women: the ATTICA Study. Heart Vessels. 2008;23(2):96–103. doi:10.1007/s00380-007-1018-5

85. Núñez-Córdoba JM, Valencia-Serrano F, Toledo E, Alonso A, Martínez-González MA. The Mediterranean diet and incidence of hypertension: the Seguimiento Universidad de Navarra (SUN) Study. Am J Epidemiol. 2009;169(3):339–346. doi:10.1093/aje/kwn335

86. Saulle R, Lia L, De Giusti M, La Torre G. A systematic overview of the scientific literature on the association between Mediterranean Diet and the Stroke prevention. Clin Ter. 2019;170(5):e396–e408. doi:10.7417/CT.2019.2166

87. Kontogianni MD, Panagiotakos DB. Dietary patterns and stroke: a systematic review and re-meta-analysis. Maturitas. 2014;79(1):41–47. doi:10.1016/j.maturitas.2014.06.014

88. Feng Q, Fan S, Wu Y, et al. Adherence to the dietary approaches to stop hypertension diet and risk of stroke: a meta-analysis of prospective studies. Medicine. 2018;97(38):e12450. doi:10.1097/MD.0000000000012450

89. Schwingshackl L, Bogensberger B, Hoffmann G. Diet quality as assessed by the healthy eating index, alternate healthy eating index, dietary approaches to stop hypertension score, and health outcomes: an updated systematic review and meta-analysis of cohort studies. J Acad Nutr Diet. 2018;118(1):74–100.e11. doi:10.1016/j.jand.2017.08.024

90. Sureda A, Bibiloni MDM, Julibert A, et al. Adherence to the mediterranean diet and inflammatory markers. Nutrients. 2018;10(1):62. doi:10.3390/nu10010062

91. Soltani S, Chitsazi MJ, Salehi-Abargouei A. The effect of dietary approaches to stop hypertension (DASH) on serum inflammatory markers: a systematic review and meta-analysis of randomized trials. Clin Nutr. 2018;37(2):542–550. doi:10.1016/j.clnu.2017.02.018

92. Schwingshackl L, Hoffmann G. Mediterranean dietary pattern, inflammation and endothelial function: a systematic review and meta-analysis of intervention trials. Nutr Metab Cardiovasc Dis. 2014;24(9):929–939. doi:10.1016/j.numecd.2014.03.003

93. Christ A, Lauterbach M, Latz E. Western diet and the immune system: an inflammatory connection. Immunity. 2019;51(5):794–811. doi:10.1016/j.immuni.2019.09.020

94. Edwards GA, Gamez N, Escobedo G, Calderon O, Moreno-Gonzalez I. Modifiable risk factors for Alzheimer’s disease. Front Aging Neurosci. 2019;11:146. doi:10.3389/fnagi.2019.00146

95. Grosso G, Mistretta A, Frigiola A, et al. Mediterranean diet and cardiovascular risk factors: a systematic review. Crit Rev Food Sci Nutr. 2014;54(5):593–610. doi:10.1080/10408398.2011.596955

96. Guasch-Ferré M, Willett WC. The Mediterranean diet and health: a comprehensive overview. J Intern Med. 2021;290(3):549–566. doi:10.1111/joim.13333

97. AlAufi NS, Chan YM, Waly MI, Chin YS, Mohd Yusof BN, Ahmad N. Application of Mediterranean diet in cardiovascular diseases and Type 2 diabetes mellitus: motivations and challenges. Nutrients. 2022;14(13):2777. doi:10.3390/nu14132777

98. Satija A, Bhupathiraju SN, Rimm EB, et al. Plant-based dietary patterns and incidence of type 2 diabetes in US men and women: results from three prospective cohort studies. PLoS Med. 2016;13(6):e1002039. doi:10.1371/journal.pmed.1002039

99. Liu RH. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr. 2004;134(12 Suppl):3479S–3485S. doi:10.1093/jn/134.12.3479S

100. Liu RH. Health-promoting components of fruits and vegetables in the diet. Adv Nutr. 2013;4(3):384S–392S. doi:10.3945/an.112.003517

101. Mahmoud AM, Hernández Bautista RJ, Sandhu MA, Hussein OE. Beneficial effects of citrus flavonoids on cardiovascular and metabolic health. Oxid Med Cell Longev. 2019;2019:5484138. doi:10.1155/2019/5484138

102. Li C, Schluesener H. Health-promoting effects of the citrus flavanone hesperidin. Crit Rev Food Sci Nutr. 2017;57(3):613–631. doi:10.1080/10408398.2014.906382

103. Millar CL, Duclos Q, Blesso CN. Effects of dietary flavonoids on reverse cholesterol transport, HDL metabolism, and HDL function. Adv Nutr. 2017;8(2):226–239. doi:10.3945/an.116.014050

104. Rees A, Dodd GF, Spencer JPE. The effects of flavonoids on cardiovascular health: a review of human intervention trials and implications for cerebrovascular function. Nutrients. 2018;10(12):1852. doi:10.3390/nu10121852

105. Gandhi GR, Vasconcelos ABS, Wu DT, et al. Citrus flavonoids as promising phytochemicals targeting diabetes and related complications: a systematic review of in vitro and in vivo studies. Nutrients. 2020;12(10):2907. doi:10.3390/nu12102907

106. Kang EY, Kim DY, Kim HK, et al. Modified Korean MIND Diet: a nutritional intervention for improved cognitive function in elderly women through mitochondrial respiration, inflammation suppression, and amino acid metabolism regulation. Mol Nutr Food Res. 2023:e2300329. doi:10.1002/mnfr.202300329

107. San-Millán I. The key role of mitochondrial function in health and disease. Antioxidants. 2023;12(4):782. doi:10.3390/antiox12040782

108. Avram VF, Merce AP, Hâncu IM, et al. Impairment of mitochondrial respiration in metabolic diseases: an overview. Int J Mol Sci. 2022;23(16):8852. doi:10.3390/ijms23168852

109. Huang L, Tao Y, Chen H, et al. Mediterranean-Dietary Approaches to Stop Hypertension Intervention for Neurodegenerative Delay (MIND) diet and cognitive function and its decline: a prospective study and meta-analysis of cohort studies. Am J Clin Nutr. 2023;118(1):174–182. doi:10.1016/j.ajcnut.2023.04.025

110. Barnes LL, Dhana K, Liu X, et al. Trial of the MIND diet for prevention of cognitive decline in older persons. N Engl J Med. 2023;389(7):602–611. doi:10.1056/NEJMoa2302368

111. Ma Y, Olendzki BC, Pagoto SL, et al. Number of 24-hour diet recalls needed to estimate energy intake. Ann Epidemiol. 2009;19(8):553–559. doi:10.1016/j.annepidem.2009.04.010

Creative Commons License © 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.